These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 15758557)
1. Differences in TSH receptor binding and thyroid-stimulating properties between TSH and Graves' IgG. Slowly-acting TSH receptor antibody moieties in Graves' sera affect assay data. Saiki Y; Ishihara T; Ikekubo K; Mori T Endocr J; 2005 Feb; 52(1):45-55. PubMed ID: 15758557 [TBL] [Abstract][Full Text] [Related]
2. Immunoglobulins of untreated Graves' patients with or without thyrotropin receptor antibody (determined by porcine thyrocytes) universally elicit potent thyroid hormone-releasing activity in cultured human thyroid follicles. Sato K; Yamazaki K; Yamada E; Kanaji Y; Miura M; Obara T Thyroid; 1999 Oct; 9(10):979-88. PubMed ID: 10560951 [TBL] [Abstract][Full Text] [Related]
3. Demonstration of anti-TSH antibody in TSH binding inhibitory immunoglobulin-positive sera of patients with Graves' disease. Ochi Y; Hamazu M; Kajita Y; Nagata A Clin Endocrinol (Oxf); 2002 Mar; 56(3):405-12. PubMed ID: 11940054 [TBL] [Abstract][Full Text] [Related]
4. The effects of nonionic polymers on thyroid stimulation and TSH receptor binding by the human monoclonal TSH receptor autoantibody M22. Ochi Y; Hamazu M; Kajita Y; Hachiya T; Miyata T; Barrett C; Smith BR Thyroid; 2009 Jan; 19(1):47-52. PubMed ID: 18976151 [TBL] [Abstract][Full Text] [Related]
5. Differences between thyrotropin receptor antibody bioactivity and inhibition of 125I-bovine thyrotropin binding. Wallaschofski H; Kaczmarek M; Miehle K; Hentschel B; Paschke R Thyroid; 2000 Oct; 10(10):897-907. PubMed ID: 11081256 [TBL] [Abstract][Full Text] [Related]
6. Antithyroid Drugs Inactivate TSH Binding to the TSH Receptor by their Reducing Action. Ochi Y; Hachiya T; Koyama Y; Fukuhori N; Ashida N Endocr Metab Immune Disord Drug Targets; 2018; 18(5):508-512. PubMed ID: 29468987 [TBL] [Abstract][Full Text] [Related]
7. Evidence against the importance in the disease process of antibodies to bovine thyroid-stimulating hormone found in some patients with Graves' disease. Noh J; Hamada N; Saito H; Oyanagi H; Ishikawa N; Momotani N; Ito K; Morii H J Clin Endocrinol Metab; 1989 Jan; 68(1):107-13. PubMed ID: 2909548 [TBL] [Abstract][Full Text] [Related]
8. Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease. Kamijo K; Murayama H; Uzu T; Togashi K; Olivo PD; Kahaly GJ Thyroid; 2011 Dec; 21(12):1295-9. PubMed ID: 22066477 [TBL] [Abstract][Full Text] [Related]
9. Thyroid-stimulating antibody and TSH-binding inhibitor immunoglobulin in 277 Graves' patients and in 686 normal subjects. Takasu N; Oshiro C; Akamine H; Komiya I; Nagata A; Sato Y; Yoshimura H; Ito K J Endocrinol Invest; 1997 Sep; 20(8):452-61. PubMed ID: 9364248 [TBL] [Abstract][Full Text] [Related]
10. [Clinical studies on abnormal thyroid stimulators in patients with Graves' disease. I. A sensitive assay for thyroid-stimulating antibodies using cultured porcine thyroid cells and polyethylene glycol precipitation of serum]. Uno C; Nishikawa M Nihon Naibunpi Gakkai Zasshi; 1988 Mar; 64(3):193-205. PubMed ID: 2899523 [TBL] [Abstract][Full Text] [Related]
11. Inhibition of TSH binding to chicken thyroid by some cases of LATS (long acting thyroid stimulator). Nakajima Y; Ishida M; Kajita Y; Ura Y; Ochi Y; Miyazaki T; Hachiya T; Ijichi H Endocrinol Jpn; 1986 Jun; 33(3):375-83. PubMed ID: 3019653 [TBL] [Abstract][Full Text] [Related]
12. Graves' immunoglobulins protect the human TSH receptor: further evidence for TSH receptor antibodies in Graves' disease. Davies TF; Platzer M Clin Endocrinol (Oxf); 1983 Oct; 19(4):427-35. PubMed ID: 6313261 [TBL] [Abstract][Full Text] [Related]
14. Precipitation of the thyrotropin receptor and identification of thyroid autoantigens using Graves' disease immunoglobulins. Heyma P; Harrison LC J Clin Invest; 1984 Sep; 74(3):1090-7. PubMed ID: 6088581 [TBL] [Abstract][Full Text] [Related]
15. Increase of thyroid stimulating activity in Graves' immunoglobulin-G by high polyethylene glycol concentrations using porcine thyroid cell assay. Inui T; Kouki T; Yamashiro K; Hachiya T; Ochi Y; Kajita Y; Sato Y; Nagata A Thyroid; 1998 Apr; 8(4):319-25. PubMed ID: 9588497 [TBL] [Abstract][Full Text] [Related]
16. Anti-TSH antibody with high specificity to human TSH in sera from a patient with Graves' disease: its isolation from, and interaction with, TSH receptor antibodies. Akamizu T; Mori T; Kasagi K; Kosugi S; Miyamoto M; Nishino K; Sugawa H; Yokota T; Nakamura H; Konishi J Clin Endocrinol (Oxf); 1987 Mar; 26(3):311-20. PubMed ID: 3652477 [TBL] [Abstract][Full Text] [Related]
17. Interaction between thyrotropin (TSH) binding inhibitor immunoglobulins (TBII) and soluble TSH receptors in fat cells. Kishihara M; Nakao Y; Baba Y; Kobayashi N; Matsukura S; Kuma K; Fujita T J Clin Endocrinol Metab; 1981 Apr; 52(4):665-70. PubMed ID: 6110672 [TBL] [Abstract][Full Text] [Related]
18. Sensitive assay to detect thyroid stimulating antibody (TSAb) in the presence of thyroid stimulation blocking antibody (TSBAb) in serum. Ochi Y; Yamashiro K; Takasu N; Kajita Y; Sato Y; Nagata A Horm Metab Res; 2001 Feb; 33(2):115-20. PubMed ID: 11294493 [TBL] [Abstract][Full Text] [Related]
19. [The effects of TSH, cholera toxin and Graves' IgG on cAMP production in cultured human thyroid adenoma cells in monolayer]. Tsuboi K Nihon Naibunpi Gakkai Zasshi; 1985 May; 61(5):541-53. PubMed ID: 2862066 [TBL] [Abstract][Full Text] [Related]
20. Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay. Maugendre D; Massart C Clin Endocrinol (Oxf); 2001 Jan; 54(1):89-96. PubMed ID: 11167931 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]